| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Docosahexaenoic Acid | Alcoholic Liver Disease | 1 | PM | 18571270 | 📋 | Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids |
| Docosahexaenoic Acid | Hepatic Fibrosis | 1 | PM | 29035816 | 📋 | Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats |
| Docosahexaenoic Acid | Hepatic Fibrosis | 2 | PM | 26315048 | 📋 | Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway |
| Docosahexaenoic Acid | Hepatic Steatosis | 3 | PM | 35761631 | 📋 | Docosahexaenoic acid-rich fish oil alleviates hepatic steatosis in association with regulation of gut microbiome in ob/ob mice |
| Docosahexaenoic Acid | Hepatic Steatosis | 1 | PM | 32620521 | 📋 | Suppression of High-Fat Diet-Induced Obesity-Associated Liver Mitochondrial Dysfunction by Docosahexaenoic Acid and Hydroxytyrosol Co-Administration |
| Docosahexaenoic Acid | Hepatic Steatosis | 2 | PM | 31454114 | 📋 | Docosahexaenoic acid and hydroxytyrosol co-administration fully prevents liver steatosis and related parameters in mice subjected to high-fat diet: A molecular approach |
| Docosahexaenoic Acid | Hepatotoxicity | 1 | PM | 34073582 | 📋 | DHA Protects Hepatocytes from Oxidative Injury through GPR120/ERK-Mediated Mitophagy |
| Docosahexaenoic Acid | Hyperbilirubinemia | 1 | PM | 38680033 | 📋 | Docosahexaenoic Acid Supplementation for Neonatal Hyperbilirubinemia: A Double-Blind, Randomized Clinical Trial |
| Docosahexaenoic Acid | Liver Cancer | 1 | PM | 16963249 | 📋 | Docosahexaenoic acid induces apoptosis in CYP2E1-containing HepG2 cells by activating the c-Jun N-terminal protein kinase related mitochondrial damage |
| Docosahexaenoic Acid | MAFLD | 6 | PM | 38430210 | 📋 | Docosahexaenoic Acid Modulates Nonalcoholic Fatty Liver Disease by Suppressing Endocannabinoid System |
| Docosahexaenoic Acid | MAFLD | 5 | PM | 33546405 | 📋 | Effects of Long-Term DHA Supplementation and Physical Exercise on Non-Alcoholic Fatty Liver Development in Obese Aged Female Mice |
| Docosahexaenoic Acid | MAFLD | 1 | PM | 32786869 | 📋 | Combined Effect of Quercetin and Fish Oil on Oxidative Stress in the Liver of Mice fed a Western-style diet |
| Docosahexaenoic Acid | MAFLD | 2 | PM | 28356106 | 📋 | Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice |
| Docosahexaenoic Acid | MAFLD | 4 | PM | 28294174 | 📋 | Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study |
| Docosahexaenoic Acid | MAFLD | 3 | PM | 23220074 | 📋 | Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children |
| Docosahexaenoic Acid | Non-Alcoholic Steatohepatitis | 2 | PM | 35189618 | 📋 | Docosahexaenoic Acid Attenuates the Progression of Nonalcoholic Steatohepatitis by Suppressing the Adipocyte Inflammation via the G Protein-Coupled Receptor 120/Free Fatty Acid Receptor 4 Pathway |
| Docosahexaenoic Acid | Non-Alcoholic Steatohepatitis | 1 | PM | 28422962 | 📋 | Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice |
